Dosage and administration
As directed by a healthcare professional. Should be taken diluted with water followed by additional water if desired.
As directed by a healthcare professional. Should be taken diluted with water followed by additional water if desired.
| Serving Size: 15 mL (1 Unit Dose) | |
| Amount Per Serving | % Daily Value* |
| Sodium 402 mg | 18% |
| (as sodium citrate 1,500 mg) | |
| *Percent Daily Value Based on a 2,000 calorie diet |
| Serving size: 30 mL (1 Unit Dose) | |
| Amount Per Serving | %Daily Value* |
| Sodium 803 mg | 36% |
| (as sodium citrate 3,000 mg) | |
| *Percent Daily Value Based on a 2,000 calorie diet |
Other ingredients: For 1,500 mg-1,002 mg/15 mL Unit Dose - Purified water, citric acid (334 mg/5 mL-1,002 mg/15 mL unit dose), sodium benzoate, flavor, sucralose
For 3,000 mg-2,004 mg/30 mL Unit Dose - Purified water, citric acid (334 mg/5 mL-2,004 mg/30 mL unit dose), sodium benzoate, flavor, sucralose
Use: Use as indicated by a healthcare professional as a dietary supplement. Sodium citrate and citric acid may be beneficial as a systemic alkalizer†
As directed by a healthcare professional. Should be taken diluted with water followed by additional water if desired.
Do not use:
If you are on a sodium restricted diet
Allergic to any of the ingredients
If pregnant or breast-feeding, ask a doctor before use.
Storage
• store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]
• preserve in tight, light-resistant containers
• protect from freezing and light
• do not use if lid is torn or broken
Questions or comments? Call-1-844-474-7464
†This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease
Distributed by:
Rising Pharma Holdings, Inc.
East Brunswick, NJ 08816
FG-42 (for 15 mL)
FG-43 (for 30 mL)
Iss.:04/2023
500 mg-334 mg/5 mL (1,500 mg-1,002 mg/15 mL Unit Dose)
Case label -
57237-319-52 (100 x 15 mL Unit-Dose Cups)
Lid Label -
57237-319-15 (Delivers 15 mL)
500 mg-334 mg/5 mL (3,000 mg-2,004 mg/30 mL Unit Dose)
Case label -
57237-319-31 (100 x 30 mL Unit-Dose Cups)
Lid Label -
57237-319-03 (Delivers 30 mL)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 543014 | citric acid 334 MG / sodium citrate 500 MG in 5 mL Oral Solution | PSN | 1 |
| 543014 | citric acid 66.8 MG/ML / sodium citrate 100 MG/ML Oral Solution | SCD | 1 |
| 543014 | citric acid 1002 MG / sodium citrate 1500 MG per 15 ML Oral Solution | SY | 1 |
| 543014 | citric acid 2004 MG / sodium citrate 3000 MG per 30 ML Oral Solution | SY | 1 |
| 543014 | citric acid 334 MG / sodium citrate 500 MG per 5 ML Oral Solution | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| ANHYDROUS CITRIC ACID Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57237-319-03 | SODIUM CITRATE AND CITRIC ACID | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 1 | |
| 57237-319-15 | SODIUM CITRATE AND CITRIC ACID | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 1 | |
| 57237-319-31 | SODIUM CITRATE AND CITRIC ACID | 100 in 1 CASE | SOLUTION | 100 | 1 | |
| 57237-319-52 | SODIUM CITRATE AND CITRIC ACID | 100 in 1 CASE | SOLUTION | 100 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57237-319-03 | ML - Milliliter | 57237-319 | ba64bfd9-1473-406f-878e-7990cd06ea2b | 1 | 2025-06-13 |
| 57237-319-15 | ML - Milliliter | 57237-319 | cf6ea407-a68a-4d08-96a3-a500af955406 | 1 | 2025-06-13 |
| 57237-319-31 | ML - Milliliter | 57237-319 | 4d461854-957e-4183-9f01-754836ac36f4 | 1 | 2025-06-13 |
| 57237-319-52 | ML - Milliliter | 57237-319 | 699f9eef-8986-4bc7-8270-798996f56833 | 1 | 2025-06-13 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57237-319 | 57237-319-15, 57237-319-52, 57237-319-03, 57237-319-31 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SODIUM CITRATE, UNSPECIFIED FORM | 1Q73Q2JULR | ACTIB |
| ANHYDROUS CITRIC ACID | XF417D3PSL | ACTIB |
| CITRIC ACID | 2968PHW8QP | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| WATER | 059QF0KO0R | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Cardinal Health 107, LLC | b3d5225c-0ee4-481e-b9ec-bc5e1321096d | 2026-06-12 | Adverse reactions | Sodium Citrate and Citric Acid |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC | 58c24504-47de-487a-ab8d-18add155ea95 | 2026-04-07 | Adverse reactions | Sodium Citrate and Citric Acid |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | Sodium Citrate and Citric Acid |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Belleview Biosciences LLC | 3245e0e5-5e7f-c3f7-e063-6394a90ac258 | 2025-07-07 | Adverse reactions | Sodium Citrate and Citric Acid |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Kesin Pharma Corporation | 3140f8fe-0644-7561-e063-6394a90a2c28 | 2025-04-21 | Adverse reactions | Sodium Citrate and Citric Acid |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | AvPAK | fe070e2e-3e72-fb84-e053-6294a90afd88 | 2025-01-09 | Adverse reactions | Sodium Citrate and Citric Acid |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Pharmaceutical Associates, Inc. | 63201a61-6ac5-41ae-8b2d-ff0d3a8ddfd5 | 2024-11-13 | Adverse reactions | Sodium Citrate and Citric Acid |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | American Health Packaging | 58fa9952-c8ab-4ebb-a073-15cc45f4832a | 2024-07-16 | Adverse reactions | Sodium Citrate and Citric Acid |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell RX, LLC | 525136c9-7758-437b-b57b-94b905786825 | 2024-05-31 | Adverse reactions | Sodium Citrate and Citric Acid |
Adverse event summaries are temporarily unavailable. Other product information remains available.